Argent Biopharma (AU:RGT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argent Biopharma Limited has announced the issuance of 600,000 unquoted equity securities under the performance rights category. These securities are scheduled for issue on October 15, 2024. This move could indicate potential growth opportunities for the company and may interest investors in the biopharmaceutical sector.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.